David S Egilman (David Egilman)

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Electron Microscopy

Systematic Review

Top Venues

New solutions : a journal of environmental and occupational health policy : NS

American journal of industrial medicine

Archives of gynecology and obstetrics

International journal of occupational and environmental health

This page only lists publications with an associated author ORCID identifier.

Publications

Triet Hao Tran, David S Egilman
Response to Micha et al. (2022) talc powder and ovarian cancer: what is the evidence? Archives of gynecology and obstetrics (2022)
Tess Bird, Joan E Steffen, Triet H Tran, David S Egilman
A Review of the Talc Industry's Influence on Federal Regulation and Scientific Standards for Asbestos in Talc. New solutions : a journal of environmental and occupational health policy : NS 31 (2) (2021)
David S Egilman, Barry Castleman, Tess Bird
Letter to the Editor regarding Bullock 2020. Critical reviews in toxicology 50 (10) (2021)
Triet Hao Tran, David S Egilman, Mark Rigler, Theresa S Emory
A Critique of Helsinki Criteria for Using Lung Fiber Levels to Determine Causation in Mesothelioma Cases. Annals of global health 87 (1) (2021)
David Madigan, David S Egilman, Murray M Finkelstein, Triet Tran, Muna Yimam
Response to Marsh, G. M., Ierardi, A. M., Benson, S. M., & Finley, B. L. (2019). Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period. Inhalation toxicology, 31(6), 213-223. Inhalation toxicology 31 (11-12) (2019)
David S Egilman
Response to Paustenbach. American journal of industrial medicine 62 (7) (2019)
David S Egilman, Joan Steffen
Commentary on "Assessment of Health Risk From Historical Use of Cosmetic Talcum Powder". New solutions : a journal of environmental and occupational health policy : NS 28 (3) (2018)
David S Egilman
The Production of Corporate Research to Manufacture Doubt About the Health Hazards of Products: An Overview of the Exponent Bakelite® Simulation Study. New solutions : a journal of environmental and occupational health policy : NS 28 (2) (2018)
David S Egilman
Response to Hessel. American journal of industrial medicine 60 (10) (2018)
David S Egilman, Tess Bird, Remi Wilson
Use of Anti-Warnings to Falsely Reassure Downstream Users: An Asbestos Example. New solutions : a journal of environmental and occupational health policy : NS 28 (3) (2018)
David S Egilman, Triet Tran
A commentary on Roggli's "The So-Called Short-Fiber Controversy". International journal of occupational and environmental health 22 (3) (2016)